ApelinDx

N/A

Report date: 2026/04/04 20:00:24

Base Information

Drug NameApelinDx
Drug Alias Nameapelin receptor agonist (TM Global Bioscience)broad-spectrum cannabidiol formulation (TM Global Bioscience)
ClassificationBiologicsNatural product/Extract
Mechanisms of ActionApelin receptor agonists
TargetsApelin receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)AlcoholismInflammation +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTM Global Bioscience LLC
China Registration ClassN/A

Develop Information

Active CompaniesTM Global Bioscience LLCUniversity Of Colorado Denver
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)AlcoholismInflammation +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A